CS logo
small CS logo
George Washington University Cancer Center

Washington, District of Columbia, United States

About George Washington University Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at George Washington University Cancer Center


During the past decade, George Washington University Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "George Washington University Cancer Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at George Washington University Cancer Center


According to Clinical.Site data, the most researched conditions in "George Washington University Cancer Center" are "Breast Cancer" (1 trials), "HPV Positive Oropharyngeal Squamous Cell Carcinoma" (1 trials), "HPV-Related Carcinoma" (1 trials), "Head and Neck Cancer" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "George Washington University Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at George Washington University Cancer Center


Most popular intervention types in "George Washington University Cancer Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "CUE-101" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Keytruda" (1 trials). Other intervention names were less common.

Clinical Trials Genders at George Washington University Cancer Center


The vast majority of trials in "George Washington University Cancer Center" are 2 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at George Washington University Cancer Center


Currently, there are NaN active trials in "George Washington University Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in George Washington University Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in George Washington University Cancer Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".